Rheumatoid factor isotypes in localized scleroderma

被引:10
作者
Mimura, Y [1 ]
Ihn, H [1 ]
Jinnin, M [1 ]
Asano, Y [1 ]
Yamane, K [1 ]
Tamaki, K [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan
关键词
D O I
10.1111/j.1365-2230.2005.01776.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Localized sclerodema is a connective tissue disorder that is sometimes accompanied by various immunological abnormalities. In this study, we analysed serum levels of rheumatoid factor (RF) isotypes in patients with localized scleroderma and in normal controls to determine if any of these isotypes reflect the severity of the disease. IgM RF, IgG RF and IgA RF were positive in 30%, 21%, and 7% of the patients, respectively. The levels of IgM RF were significantly higher in the patients with generalized morphea (GM), the most severe form of localized scleroderma, than those with linear scleroderma (LS) (P < 0.005) or normal controls (P < 0.0005). The levels of IgG RF were significantly higher in patients with GM than normal controls (P < 0.05). The levels of IgA RF were significantly higher in patients with GM or LS than normal controls (P < 0.001 and P < 0.01, respectively). The count of sclerotic lesions was significantly higher in patients with IgM RF than those without (P < 0.05). These results suggest that the presence of RF isotypes is one of the immunological abnormalities of localized scleroderma. IgM RF seemed to be most useful of these three factors to determine the severity of disease.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 24 条
[1]
CARSON DA, TXB RHEUMATOLOGY, P155
[2]
DISEASE-ACTIVITY AND JOINT DAMAGE PROGRESSION IN EARLY RHEUMATOID-ARTHRITIS - RELATION TO IGG, IGA, AND IGM RHEUMATOID-FACTOR [J].
EBERHARDT, KB ;
TRUEDSSON, L ;
PETTERSSON, H ;
SVENSSON, B ;
STIGSSON, L ;
EBERHARDT, JL ;
WOLLHEIM, FA .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (11) :906-909
[3]
SIGNIFICANCE OF RHEUMATOID-FACTOR ISOTYPES IN SERONEGATIVE RHEUMATOID-ARTHRITIS [J].
EGGELMEIJER, F ;
OTTEN, HG ;
DEROOY, HH ;
DAHA, MR ;
BREEDVELD, FC .
RHEUMATOLOGY INTERNATIONAL, 1990, 10 (01) :43-46
[4]
LINEAR SCLERODERMA - CLINICAL SPECTRUM, PROGNOSIS, AND LABORATORY ABNORMALITIES [J].
FALANGA, V ;
MEDSGER, TA ;
REICHLIN, M ;
RODNAN, GP .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :849-857
[5]
Houssien DA, 1997, J RHEUMATOL, V24, P2119
[6]
Ichikawa Y, 1998, CLIN EXP RHEUMATOL, V16, P709
[7]
Ihn H, 1996, BRIT J DERMATOL, V134, P843
[8]
CLINICAL-EVALUATION OF SCLERODERMA SPECTRUM DISORDERS USING A POINTS SYSTEM [J].
IHN, H ;
TAMAKI, T ;
SOMA, Y ;
TSUCHIDA, T ;
ISHIBASHI, Y ;
TAKEHARA, K .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1992, 284 (07) :391-395
[9]
Ihn H, 2000, J RHEUMATOL, V27, P698
[10]
DEMONSTRATION OF INTERLEUKIN-2, INTERLEUKIN-4 AND INTERLEUKIN-6 IN SERA FROM PATIENTS WITH LOCALIZED SCLERODERMA [J].
IHN, H ;
SATO, S ;
FUJIMOTO, M ;
KIKUCHI, K ;
TAKEHARA, K .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (02) :193-197